Title: 
Official Title: To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Establishment of drug adherence guidelinesTitle XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following:1712.Establishment of drug adherence guidelines(a)In generalThe Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.(b)ContentsIn establishing the guidelines under subsection (a), the Secretary shall—(1)incorporate artificial intelligence and machine learning technologies; and(2)to the maximum extent practicable, promote the use of generic and biosimilar drugs.(c)DefinitionsIn this section:(1)Medicare part b drugThe term Medicare part B drug means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.). (2)Medicare part d drugThe term Medicare part D drug means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e)))..

Section 2:
1712.Establishment of drug adherence guidelines(a)In generalThe Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.(b)ContentsIn establishing the guidelines under subsection (a), the Secretary shall—(1)incorporate artificial intelligence and machine learning technologies; and(2)to the maximum extent practicable, promote the use of generic and biosimilar drugs.(c)DefinitionsIn this section:(1)Medicare part b drugThe term Medicare part B drug means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.). (2)Medicare part d drugThe term Medicare part D drug means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e))).


================================================================================

Raw Text:
119 HR 1142 IH: To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
U.S. House of Representatives
2025-02-07
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 1142IN THE HOUSE OF REPRESENTATIVESFebruary 7, 2025Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.1.Establishment of drug adherence guidelinesTitle XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following:1712.Establishment of drug adherence guidelines(a)In generalThe Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.(b)ContentsIn establishing the guidelines under subsection (a), the Secretary shall—(1)incorporate artificial intelligence and machine learning technologies; and(2)to the maximum extent practicable, promote the use of generic and biosimilar drugs.(c)DefinitionsIn this section:(1)Medicare part b drugThe term Medicare part B drug means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.). (2)Medicare part d drugThe term Medicare part D drug means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e)))..